Trade STLN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Starling Oncology, Inc. (STLN) is trading at US$6.30, down 0.79% today as of Oct 5, 16:00 EDT. The company has a market capitalisation of US$658.89M. Over the past 52 weeks, STLN has traded between US$2.32 and US$7.13. On Syfe you can trade STLN with $0 commission and add it to your watchlist.
| Previous close | US$6.35 |
|---|---|
| Market cap | US$658.89M |
| 52-week range | US$2.32 – US$7.13 |
| Volume | 1.34M |
| Exchange | US |
Starling Oncology, Inc.
Starling Oncology, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
Year: 2021
B. Riley Adjusts Price Target on Starling Oncology to $11 From $8, Maintains Buy Rating
Aug 7, 2:09 PM · MT Newswires
Starling Oncology, Inc. (STLN) stock is trading at US$6.30, -0.79% from the previous close of US$6.35.
The market cap for Starling Oncology, Inc. (STLN) stock is approximately US$658.89M.
The 52-week high for Starling Oncology, Inc. (STLN) stock is US$7.13.
The 52-week low for Starling Oncology, Inc. (STLN) stock is US$2.32.
Starling Oncology, Inc. (STLN) does not currently pay a dividend.
Stay on top of STLN
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
